학술논문

P06: UPDATED RESULTS FROM THE PHASE 1/2 MAJESTEC‐1 STUDY OF TECLISTAMAB, A B‐CELL MATURATION ANTIGEN X CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA.
Document Type
Article
Source
HemaSphere; Apr2022 Supplement 1, Vol. 6, p14-14, 1p
Subject
Language
ISSN
25729241